A. Malmström 2026-11-05
A. Malmström coauthored, with L. Åberg, a 1982 assay for the chondroitin-glucuronate 5-epimerase activity involved in dermatan sulfate biosynthesis. The reaction changes the stereochemical configuration of sugar residues already attached to a polysaccharide, rather than synthesizing a free sugar first.[ref]
Biosynthesis of dermatan sulphate. Assay and properties of the uronosyl C-5 epimerase by A. Malmström and L. Åberg. Original byline and Abstract: polymer-level reaction
The experiment used chondroitin carrying tritium at the reacting carbon. Release of the label during incubation was measured with a scintillation counter, converting a hard-to-see molecular exchange into a countable assay signal.[ref]
Biosynthesis of dermatan sulphate. Assay and properties of the uronosyl C-5 epimerase by A. Malmström and L. Åberg. Abstract: labelled substrate, distillation and liquid-scintillation counting
The preparations also distinguished activities associated with dermatan sulfate and heparan sulfate biosynthesis through different requirements for pH and cofactors. Similar overall epimerization chemistry therefore did not establish that the same enzyme performed both biological tasks.[ref]
Biosynthesis of dermatan sulphate. Assay and properties of the uronosyl C-5 epimerase by A. Malmström and L. Åberg. Abstract: two microsomal epimerase activities
Chondroitin 2026-11-05
Chondroitin is a glycosaminoglycan backbone built from alternating glucuronic acid and N-acetylgalactosamine residues with a defined glycosidic bond pattern. Chondroitin sulfate adds sulfate substitutions to that framework; the backbone name alone does not specify a sulfation pattern.[ref]
Identification and molecular cloning of a chondroitin synthase from Pasteurella multocida type F by P. L. DeAngelis and A. J. Padgett-McCue. Abstract: chondroitin disaccharide repeat and enzymatic synthesis
A 2000 experiment cloned chondroitin synthase from Pasteurella multocida type F. A recombinant soluble enzyme extended acceptor chains using the corresponding activated sugar donors. Related donor molecules did not substitute in the tested reaction. The product was susceptible to a chondroitin-cleaving enzyme but resistant to a hyaluronan-cleaving enzyme, providing a structural check beyond simply observing a large carbohydrate product.[ref]
Identification and molecular cloning of a chondroitin synthase from Pasteurella multocida type F by P. L. DeAngelis and A. J. Padgett-McCue. Abstract: donor specificity, size-exclusion chromatography and contrasting lyase susceptibility
For an original comparison, a segment with 25 complete repeats contains 25 uronic-acid and 25 amino-sugar residues. Adding sulfate substitutions leaves that sugar count unchanged. Converting eligible D-glucuronate positions into L-iduronate also leaves the count unchanged, but leads toward a dermatan-type chain through chondroitin-glucuronate 5-epimerase.[ref]
Chondroitin-glucuronate 5-epimerase in IUBMB Enzyme Nomenclature. EC5.1.3.19: chondroitin D-glucuronate to dermatan L-iduronate
A composition measurement, an enzyme cleavage test and a measurement of chain length therefore answer different questions. Agreement among them helps establish polymer identity without equating every negatively charged polysaccharide with the same molecule.
Chondroitin-glucuronate 5-epimerase 2026-11-05
Chondroitin-glucuronate 5-epimerase changes D-glucuronate residues in a chondroitin chain into L-iduronate residues in a dermatan chain. Its classification is EC 5.1.3.19. The reaction alters carbon-5 stereochemistry without adding a sugar residue or changing the residue's elemental formula.[ref]
Chondroitin-glucuronate 5-epimerase in IUBMB Enzyme Nomenclature. Reaction and accepted name
This connects polymer modification to dermatan sulfate formation. It is a different enzyme assignment from heparosan-N-sulfate-glucuronate 5-epimerase, whose substrate belongs to another polysaccharide pathway. Similar names do not make the polymer substrates interchangeable.[ref]
Chondroitin-glucuronate 5-epimerase in IUBMB Enzyme Nomenclature. Comments, distinction from EC 5.1.3.17
In 1982, A. Malmström and L. Åberg reported distinct uronosyl-epimerase activities associated with dermatan- and heparan-sulfate biosynthesis in microsomal preparations from cultured fibroblasts. The comparison made substrate context experimentally relevant rather than treating all carbon-5 epimerization as one nonspecific activity.[ref]
Biosynthesis of dermatan sulphate. Assay and properties of the uronosyl C-5 epimerase by A. Malmström and L. Åberg. Abstract, two microsomal epimerase activities
For a constructed 50-position substrate segment, conversion of ten eligible glucuronate residues yields ten iduronate residues and 40 unchanged positions. The chain still contains 50 positions. A measurement sensitive only to total sugar amount or shared molecular mass cannot establish that this stereochemical conversion occurred.
Dermatan sulfate 2026-11-05
Dermatan sulfate is a family of sulfated glycosaminoglycans containing repeating iduronic acid and N-acetylgalactosamine units. The sugar linkage pattern and sulfate substitutions help define the material; chain length and substitution vary, so the name does not identify one small molecule with a unique molecular mass.[ref]
Its uronic-acid stereochemistry can be created after a chain has been assembled. Chondroitin-glucuronate 5-epimerase converts D-glucuronate residues in a chondroitin chain into L-iduronate residues in a dermatan chain. This enzyme is distinct from heparosan-N-sulfate-glucuronate 5-epimerase, which acts in a different polysaccharide context.[ref]
Chondroitin-glucuronate 5-epimerase in IUBMB Enzyme Nomenclature. EC 5.1.3.19, Reaction and Comments
An ideal segment of 20 complete two-sugar repeats contains 20 uronic-acid residues and 20 amino-sugar residues, or 40 sugar residues altogether. Epimerizing an eligible uronic-acid residue changes its configuration without increasing that total. Adding a sulfate group changes substitution without adding another sugar residue.
These distinctions guide an experiment: measuring chain extension, uronic-acid configuration and sulfate content asks three separate questions. A total carbohydrate measurement alone cannot determine which operation occurred. To compare two preparations meaningfully, record the property actually measured rather than assuming every dermatan-sulfate chain has identical composition.